Sub Heading

Clinical Trials Details

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

IRB Protocol Number
A032302

Clinical Trial Categories

  • Prostate Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men 18+ years old, with diagnosis of metastatic adenocarcinoma of the prostate without small cell histology, and no prior chemotherapy for prostate cancer. 

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.